产品编号:B677393
产品规格:10mg
产品价格:面议
| 标准品编号: | B677393 |
| 名称: | Brilanestrant |
| 别名: | E)-3-[4-[(E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl]phenyl]-2-propenoic Acid; (E)-3-[4-[(E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl]phenyl]acrylic Acid: ARN 810; GDC 0810; RG 6046; RO 7056118 |
| CAS号: | 1365888-06-7 |
| 分子式: | C₂₆H₂₀ClFN₂O₂ |
| 分子量: | 446.9 |
| 类别: | Research Tools; Standards; Molecular Biology; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Brilanestrant is an orally bioavailable Selective Estrogen Receptor Degrader (SERD) that demonstrates robust activity in tamoxifen-resistant breast cancer xenografts. GDC-0810 functions by binding to the estrogen receptor, inducing a conformational change resulting in the degradation of the receptor. GDC-0810 or ARN-810 demonstrates robust activity in models of tamoxifen-sensitive and tamoxifen-resistant breast cancer, and is currently in clinical trials in women with locally advanced or metastatic estrogen receptor-positive breast cancer. |
| 参考文献 | |